These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7935164)

  • 41. Recombinant modified vaccinia virus Ankara expressing a soluble form of glycoprotein B causes durable immunity and neutralizing antibodies against multiple strains of human cytomegalovirus.
    Wang Z; La Rosa C; Maas R; Ly H; Brewer J; Mekhoubad S; Daftarian P; Longmate J; Britt WJ; Diamond DJ
    J Virol; 2004 Apr; 78(8):3965-76. PubMed ID: 15047812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine.
    Greenway TE; Eldridge JH; Ludwig G; Staas JK; Smith JF; Gilley RM; Michalek SM
    Vaccine; 1995; 13(15):1411-20. PubMed ID: 8578818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a micro-neutralization assay for ebolaviruses using a replication-competent vesicular stomatitis hybrid virus and a quantitative PCR readout.
    Lee SS; Phy K; Peden K; Sheng-Fowler L
    Vaccine; 2017 Oct; 35(41):5481-5486. PubMed ID: 28427845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection.
    Cai Y; Liu Q; Huang X; Li D; Ku Z; Zhang Y; Huang Z
    Vaccine; 2013 Apr; 31(18):2215-21. PubMed ID: 23499596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the induction of specific cytotoxic T lymphocytes following immunization of F1 hybrid mice with rabies antigens.
    Morgeaux S; Joffret ML; Leclerc C; Sureau P; Perrin P
    Res Virol; 1989; 140(3):193-206. PubMed ID: 2547236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. B7 costimulation is critical for antibody class switching and CD8(+) cytotoxic T-lymphocyte generation in the host response to vesicular stomatitis virus.
    McAdam AJ; Farkash EA; Gewurz BE; Sharpe AH
    J Virol; 2000 Jan; 74(1):203-8. PubMed ID: 10590107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.
    Stittelaar KJ; Boes J; Kersten GF; Spiekstra A; Mulder PG; de Vries P; Roholl PJ; Dalsgaard K; van den Dobbelsteen G; van Alphen L; Osterhaus AD
    Vaccine; 2000 May; 18(23):2482-93. PubMed ID: 10775782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative and qualitative analyses of the immune responses induced by a multivalent minigene DNA vaccine.
    An LL; Rodriguez F; Harkins S; Zhang J; Whitton JL
    Vaccine; 2000 Apr; 18(20):2132-41. PubMed ID: 10715528
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of viral membrane fusion activity on antibody induction by influenza H5N1 whole inactivated virus vaccine.
    Geeraedts F; ter Veer W; Wilschut J; Huckriede A; de Haan A
    Vaccine; 2012 Oct; 30(45):6501-7. PubMed ID: 22841974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of hydrostatic pressure on a membrane-enveloped virus: high immunogenicity of the pressure-inactivated virus.
    Silva JL; Luan P; Glaser M; Voss EW; Weber G
    J Virol; 1992 Apr; 66(4):2111-7. PubMed ID: 1312621
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of antibody concentration and avidity in antiviral protection.
    Bachmann MF; Kalinke U; Althage A; Freer G; Burkhart C; Roost H; Aguet M; Hengartner H; Zinkernagel RM
    Science; 1997 Jun; 276(5321):2024-7. PubMed ID: 9197261
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR; Mackett M; Lefrancois L; Lyles DS; Moss B
    J Exp Med; 1986 Jun; 163(6):1529-38. PubMed ID: 3011949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral immunization with different assembly forms of the HPV 16 major capsid protein L1 induces neutralizing antibodies and cytotoxic T-lymphocytes.
    Thönes N; Müller M
    Virology; 2007 Dec; 369(2):375-88. PubMed ID: 17822733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. H-2L-restricted recognition of viral antigens In the H-2d haplotype, anti-vesicular stomatitis virus cytotoxic T cells are restricted solely by H-2L.
    Ciavarra R; Forman J
    J Exp Med; 1982 Sep; 156(3):778-90. PubMed ID: 6286837
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How many specific B cells are needed to protect against a virus?
    Bachmann MF; Kündig TM; Kalberer CP; Hengartner H; Zinkernagel RM
    J Immunol; 1994 May; 152(9):4235-41. PubMed ID: 7512589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity.
    Roost HP; Bachmann MF; Haag A; Kalinke U; Pliska V; Hengartner H; Zinkernagel RM
    Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1257-61. PubMed ID: 7877965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector.
    Publicover J; Ramsburg E; Rose JK
    J Virol; 2005 Nov; 79(21):13231-8. PubMed ID: 16227246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Induction of optimal anti-viral neutralizing B cell responses by dendritic cells requires transport and release of virus particles in secondary lymphoid organs.
    Ludewig B; Maloy KJ; López-Macías C; Odermatt B; Hengartner H; Zinkernagel RM
    Eur J Immunol; 2000 Jan; 30(1):185-96. PubMed ID: 10602040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A formalin-fixed whole SIV vaccine induces protective responses that are cross-protective and durable.
    Murphey-Corb M; Ohkawa S; Davison-Fairburn B; Martin LN; Baskin GB; Langlois AJ; McIntee M; Narayan O; Gardner MB
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1475-8. PubMed ID: 1466986
    [No Abstract]   [Full Text] [Related]  

  • 60. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
    Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
    AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.